These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 24224572)

  • 41. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
    Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder.
    Walker G; Römann P; Poller B; Löbmann K; Grohganz H; Rooney JS; Huff GS; Smith GPS; Rades T; Gordon KC; Strachan CJ; Fraser-Miller SJ
    Mol Pharm; 2017 Dec; 14(12):4675-4684. PubMed ID: 29091447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of crystal morphology and mill type on milling induced crystal disorder.
    Chikhalia V; Forbes RT; Storey RA; Ticehurst M
    Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
    Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
    Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin.
    Priemel PA; Grohganz H; Gordon KC; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2012 Sep; 82(1):187-93. PubMed ID: 22683936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
    Varshosaz J; Tavakoli N; Salamat FA
    Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined Effect of the Preparation Method and Compression on the Physical Stability and Dissolution Behavior of Melt-Quenched Amorphous Celecoxib.
    Be Rziņš KR; Fraser-Miller SJ; Di R; Liu J; Peltonen L; Strachan CJ; Rades T; Gordon KC
    Mol Pharm; 2021 Mar; 18(3):1408-1418. PubMed ID: 33586988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solid dispersion prepared by continuous cogrinding in an air jet mill.
    Muehlenfeld C; Kann B; Windbergs M; Thommes M
    J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicochemical, crystallographic, thermal, and spectroscopic behavior of crystalline and X-ray amorphous ciclesonide.
    Feth MP; Volz J; Hess U; Sturm E; Hummel RP
    J Pharm Sci; 2008 Sep; 97(9):3765-80. PubMed ID: 17975810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.
    Theil F; Anantharaman S; Kyeremateng SO; van Lishaut H; Dreis-Kühne SH; Rosenberg J; Mägerlein M; Woehrle GH
    Mol Pharm; 2017 Jan; 14(1):183-192. PubMed ID: 28043131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Paluch KJ; Tajber L; Grembecka M; Hawelek L; Wojnarowska Z; Grzybowska K; Talik E; Paluch M
    Eur J Pharm Sci; 2014 Oct; 62():132-40. PubMed ID: 24907679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Co-milling of telmisartan with poly(vinyl alcohol)--An alkalinizer free green approach to ensure its bioavailability.
    Isaac J; Ganguly S; Ghosh A
    Eur J Pharm Biopharm; 2016 Apr; 101():43-52. PubMed ID: 26829378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
    Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
    Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.